Glucocorticoid inhibition of fibroblast proliferation and regulation of the cyclin kinase inhibitor p21(Cip1)

Molecular Endocrinology

Volumn 11, Issue 5, 1997, Pages 577-586

  Ramalingam, Arivudainambi ^a   Hirai, Aki ^a   Thompson, E Aubrey ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN KINASE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; PROTEIN P21; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; ENZYME REGULATION; FIBROBLAST; INHIBITION KINETICS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0030943292     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.5.9923     Document Type: Article

References (73)

1. Durant S, Duval D, Homo-Delarche F 1986 Factors involved in the control of fibroblast proliferation by glucocorticoids: a review. Endocr Rev 7:254-269
2. Berliner DL 1965 Studies of the mechanisms by which cells become resistant to corticosteroids. Cancer Res 25:1085-1095
3. Ruhman AG, Berliner DL 1965 Effect of steroids on growth of mouse fibroblasts in vitro. Endocrinology 76:916-927
4. Pratt WB, Aronow L 1966 The effects of glucocorticoid on protein, nucleic acid synthesis in mouse fibroblasts growing in vitro. J Biol Chem 241:5244-5262
5. Frost GH, Rhee K, Ma T, Thompson EA Expression of c-Myc in glucocorticoid-treated fibroblastic cells. J Steroid Biochem Mol Biol 50:109-119, 1994
6. Forsthoefel AM, Thompson EA 1987 Glucocorticoid regulation of transcription of the c-Myc cellular protooncogene in P 1798 cells. Mol Endocrinol 1:899-907
7. Reisman, D, Thompson EA 1995 Glucocorticoid regulation of cyclin D 3 gene transcription, mRNA stability in lymphoid cells. Mol Endocrinol 9:1500-1509
8. Rhee K, Bresnahan W, Hirai A, Hirai M, Thompson EA 1995 c-Myc, cyclin D 3 (CcnD3) are independent targets for glucocorticoid inhibition of lymphoid cell proliferation. Cancer Res 55:4188-4195
9. Rhee K, Reisman D, Bresnahan W, Thompson EA 1995 Glucocorticoid regulation of G 1 cyclin-dependent kinase genes in lymphoid cells. Cell Growth Differ 6:691-698
10. Pines J 1993 Cyclins, cyclin-dependent kinases: take your partners. Trends Biochem Sci 18:195-197
11. Draetta GF 1994 Mammalian G 1 cyclins. Curr Opin Cell Biol 6:842-846, 1994
12. Sherr CJG 1994 1 phase progression: Cycling on cue. Cell 79:551-555
13. Hunter T, Pines J 1994 Cyclins and cancer. II. Cyclin D and CDK inhibitors comes of age. Cell 79:993-1006
14. Murray A 1994 Cell cycle check points. Curr Opin Cell Biol 6:872-876
15. Elledge SJ, Harper JW 1994 Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin Cell Biol 6:847-852
16. Sherr CJ, Roberts JM 1995 Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163
17. Serrano M, Hannon GJ, Beach DA 1993 New regulatory motif in cell-cycle control causing specific inhibition of cyclin D/ CDK 4. Nature 366:704-707
18. Hirai H, Roussel MF, Kato J, Ashmun RA, Sherr CJ 1995 Novel INK 4 proteins, p19, p18, are specific inhibitors of the cyclin D-dependent kinases CDK4, CDK6. Mol Cell Biol 15:2672-2681
19. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257-261
20. Reynisdottir I, Polyak K, Iavarone A, Massague J 1995 Kip/Cip, Ink 4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 9:1831-1845
21. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ 1993 The p 21 Cdk-interacting protein is a potent inhibitor of G1 cyclin-dependent kinases. Cell 805-816
22. Gu Y, Truck CW, Morgan DO 1993 Inhibition of CDK 2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707-710
23. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D 1993 p 21 is a universal inhibitor of cyclin kinases. Nature 366:701-704
24. Zhang H, Hannon GJ, Beach D 1994 p21-containing cyclin kinases exist in both active, inactive states. Genes Dev 8:1750-1758
25. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WD, Kinzler KW, Vogelstein B 1993 WAF1, a potential mediator of p 53 tumor suppression. Cell 75:817-825
26. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR 1994 Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90-98
27. Waga S, Hannon GJ, Beach D, Stillman B 1994 The p 21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578
28. Li R, Waga S, Hannon GJ, Beach D, Stillman B 1994 Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371:534-537
29. Halvey O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB 1995 Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by Myo D. Science 267:1018-1021
30. Cip1 in muscle, other terminally differentiating cells. Science 267:1024-1027
31. Skapek SX, Rhee J, Spicer DB, Lassar AB 1995 Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022-1024
32. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β, contact inhibition to cell cycle arrest. Genes Dev 8:9-22
33. Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487-496
34. Kip1, a cyclin-dependent kinase inhibitor, a potential mediator of extracellular antimitogenic signals. Cell 78:59-66
35. Slingerland JM, Hengst L, Pan CH, Alexander D, Stampfer MF, Reed SI 1994 A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol Cell Biol 14:3683-3694
36. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA 1992 Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006
37. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ 1993 Direct binding of cyclin D to the retinoblastoma gene product (pRb), pRb phosphorylation by the cyclin D-dependent kinase, CDK 4. Genes Dev 7:331-342
38. Zhu L, Enders G, Lees JA, Beijersbergen RL, Bernards R, Harlow E 1995 The pRb-related protein p 107 contains two growth suppression domains: independent interactions with E2F, cyclin/cdk complexes. EMBO J 14:1904-1913
39. Buchkovich K, Duffy LA, Harlow E 1989 The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105
40. DeCapiro JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwinca-Worms H, Huang C, Livingston DM 1989 The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095
41. Ludlow JW, DeCapiro JA, Huang CM, Lee WH, Paucha E, Livigston DM 1989 SV 40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56:57-65
42. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM 1993 Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497
43. Lukas J, Muller H, Bartkova J, Spitkovsky D, Kjerulff AA, Jansen-Durr P, Strauss M, Bartek J 1994 DNA tumor virus oncoproteins, retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 125:625-638
44. Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J 1995 Cyclin D 1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol 15:2600-2611
45. Lukas J, Parry D, Loise A, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J 1995 Retinoblastoma-protein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature 375:503-506
46. Nevins JR 1992 E2F: a link between the Rb tumor suppressor protein, viral oncoproteins. Science 258:424-429
47. Weinberg RA 1995 The retinoblastoma protein, cell cycle control. Cell 81:323-330
48. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ 1991 Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of cell cycle. Cell 65:701-713
49. Ajchenbaum F, Ando K, DeCapiro JA, Griffin JD 1993 Independent regulation of human D-type cyclin gene expression during G 1 phase in primary human T lymphocytes. J Biol Chem 268:4113-4119
50. Sewing A, Burger C, Brusselbach S, Schalk C, Lucibello FC, Muller R 1993 Human cyclin D 1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors, suppressed by cyclic AMP. J Cell Sci 104:545-555
51. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G 1993 Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7:812-821
52. Quelle DE, Ashmun RA, Shurtleff SA, Kato J, Bar-Sagi D, Roussel MF, Sherr CJ 1993 Overexpression of mouse D-type cyclins accelerate G 1 phase in rodent fibroblasts. Genes Dev 7:1559-1571
53. Thompson EA, Ko TC, Beauchamp RD 1996 TGF-β inhibition of intestinal epithelial cell proliferation: G1 cyclins, cyclin-dependent kinases, cyclin kinase inhibitors. In: Vedeckis WV (ed) Hormones and Cancer. Birkhauser, Boston, pp 43-72
54. Housley PR, Forsthoefel AM 1989 Isolation, characterization of a mouse L cell variant deficient in glucocorticoid receptors. Biochem Biophys Res Commun 164:480-487
55. Barrett TJ, Vig E, Vedeckis WV 1996 Coordinate regulation of glucocorticoid receptor and c-jun gene expression is cell type-specific and exhibits differential hormone sensitivity for down- and up-regulation. Biochemistry 36:9746-9753
56. DeCapiro JA, Furukawa Y, Ajchenbaum F, Griffin JD, Livingston DM 1992 The retinoblastoma susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc Natl Acad Sci USA 89:1795-1798
57. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA 1993 Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511
58. Wang JYJ, Knudsen ES, Welch PJ 1994 The retinoblastoma tumor suppressor protein. Adv Cancer Res 64:25-85
59. Cavanaugh AH, Hempel WM, Taylor LJ, Rogalsky V, Todorov G, Rothblum LI 1995 Activity of RNA polymerase I transcription UBF blocked by Rb gene product. Nature 374:177-180
60. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato J 1994 D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066-2076
61. Meyerson M, Harlow E 1994 Identification of a G 1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 14:2077-2986
62. Akiyama T, Ohuchi T, Sumida S, Matsumoto K, Toyoshima K 1992 Phosphorylation of the retinoblastoma protein by cdk 2. Proc Natl Acad Sci USA 89:7900-7904
63. Dulic V, Lees E, Reed SI 1992 Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958-1961
64. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S Nishimoto T, Morgan DO, Franza BR, Roberts JM 1992 Formation and activation of a cyclin E-cdk 2 complex during the G1 phase of the human cell cycle. Science 257:1689-1694
65. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M 1995 Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15:2612-2624
66. Resnitzky D, Reed RI 1995 Different roles for cyclins D1, E in regulation of the G1-to-S transition. Mol Cell Biol 15:3463-3469
67. Lew DJ, Marini NJ, Reed SI 1992 Different G 1 cyclins control the timing of cell cycle commitment in mother, daughter cell of the budding yeast S. cerevisiae. Cell 69:317-327
68. Laiho M, DeCapiro JA, Ludlow JW, Livingston DM, Massague' J 1990 Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175-185
69. Ko TC, Sheng HM, Reisman D, Thompson EA, Beauchamp RD 1995 Transforming growth factor-β1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 10:177-184
70. Watts CKW, Sweeney KJE, Warlters A, Musgrove EA, Sutherland RL 1994 Antiestrogen regulation of cell cycle progression, cyclin D1 gene expression in MCF-7 human breast cancer cells. Cancer Res Treat 31:95-105
71. Goya L, Maiyar A, Ge Y, Firestone GL 1993 Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-β. Mol Endocrinol 7:1121-1132
72. Frost GH, Rhee K, Thompson EA 1993 Glucocorticoid regulation of thymidine kinase (Tk-1) expression in L 929 cells. J Biol Chem 268:6748-6754
73. Bradford MM 1976 A rapid, sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248-254